|
Currently, Dennis Arthur Ausiello occupies the position of Board of Advisor at InCube Venture Partners LLC. Dr. Ausiello is also Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Professor-Clinical Medicine at Harvard Medical School and Member of Institute of Medicine of The National Academies of Science and on the board of 12 other companies.
In his past career Dennis Arthur Ausiello held the position of Lead Independent Director at Pfizer Inc., Chief Scientific Officer for Mass General Brigham, Inc. and Chairman-Medicine Emeritus at The General Hospital Corp. (a subsidiary of Mass General Brigham, Inc.), Director-Human Genetics at The Broad Institute, Inc. and President at Association of American Physicians.
Dr. Ausiello received an undergraduate degree from Harvard College and a doctorate from the University of Pennsylvania.
|
Postes et responsabilités de Dennis Arthur Ausiello | |
|
Nom | Titre |
Depuis |
Alnylam Pharmaceuticals, Inc. (Recherche biotechnologique et médicale) |
Independent Director |
2012 | Seres Therapeutics, Inc. (Recherche biotechnologique et médicale) |
Independent Director |
2015 | Rani Therapeutics Holdings, Inc. (Recherche biotechnologique et médicale) |
Independent Director |
2021 | Polyphor AG
|
Vice Chairman |
2021 | KinDex Pharmaceuticals, Inc. |
Director |
- | TARIS BioMedical LLC |
Director |
2009 | EnBiotix, Inc. |
Director |
- | Research!America |
Director-Emeritus |
2015 | Center For Assessment Technology & Continuous Health |
Director |
- | Rani Therapeutics LLC |
Director |
2018 | Institute for Human Genetics & Research |
Director |
- | Tarveda Therapeutics, Inc. |
Director |
- | Institute of Medicine of The National Academies of Science |
Member |
- | Harvard Medical School |
Professor-Clinical Medicine |
- | National Academy of Medicine (United States) |
Member |
- | American Academy of Arts & Sciences |
Member |
- | National Academy of Sciences |
Member |
- | InCube Venture Partners LLC |
Board of Advisor |
- |
|
Participations de Dennis Arthur Ausiello | |
|
Nom | Actions | % | Valorisation |
Alnylam Pharmaceuticals, Inc. (ALNY) (Recherche biotechnologique et médicale) | 3 636 | 0,0029% | 724 291 USD |
Rani Therapeutics LLC | 143 229 | 0,46% | 673 176 USD |
Spexis AG (POLN) (Produits pharmaceutiques) | 488 379 | 0,98% | 215 092 USD |
Rani Therapeutics Holdings, Inc. | 92 074 | 0,0000% | 0 USD |
Seres Therapeutics, Inc. (MCRB) (Recherche biotechnologique et médicale) | 0 | 0,0000% | 0 USD |
Rani Therapeutics Holdings, Inc. (RANI) (Recherche biotechnologique et médicale) | 0 | 0,0000% | 0 USD |
|
Dennis Arthur Ausiello: Réseau personnel | |
|
|
© 2023 People and Ownership :
|
Dennis Arthur Ausiello : Connexions | |
|
|
|